- The White House is contacting state governors to ask them to prepare to begin vaccinating children against COVID-19
- The Biden administration believes the FDA’s decision on Pfizer-BioNtech’s COVID vaccine in children could come as early as November
- Nearly 65 million pediatric doses have been purchased by the federal government for the 29 million children who will now become eligible
- Weekly child COVID cases reached over 243,000 in early September, but dropped to 148,000 by last week
- Parents are split 50/50 on whether or not to vaccinate their children as children make up 0.1% of all COVID deaths in the US
The Biden administration is quietly asking states to prepare to vaccinate young children against COVID-19 next month.
Recently, Pfizer-BioNtech submitted an application US Food and Drug Administration (FDA) To expand your COVID emergency use Vaccine to include children aged five to 11 years.
An unnamed White House official told NBC News That the federal government is telling state governors that it expects authorization to arrive in the next few weeks, as early as November.
In addition, a Department of Health and Human Services official told the news outlet that the Biden administration has already purchased 65 million pediatric doses of Pfizer’s vaccine.
This is more than the two doses needed to fully vaccinate the 29 million children in the US who will now become eligible.
The White House is contacting state governors to ask them to prepare to begin vaccinating children against COVID-19. Image: Marisol Gerardo, 9, is held by her mother as she receives a shot at the Pfizer COVID trial in April 2021 at Duke Health in Durham, North Carolina.
The Biden administration believes the FDA’s decision on Pfizer-BioNtech’s Kovid vaccine in children could come as early as November. Image: Biden speaks after signing three declarations restoring protection for national monuments, October 2021
According to ClinicalTrials.gov, Pfizer’s studies in young children worked just as well as in older children and adults.
A total of 4,500 young children aged six months and older were enrolled at nearly 100 clinical trial sites in 26 US states, Finland, Poland and Spain.
Of those children, 2,268 were between the ages of five and 11.
In a group of five to 11, about half were given two doses 21 days apart and the other half were given placebo shots.
The team then tested the safety, tolerability and immune response generated by the vaccine by measuring antibody levels in young subjects.
Pfizer said it has selected a lower dose for COVID-19 vaccine trials in children than in adolescents and adults.
Weekly child Covid cases reached over 243,000 in early September, but dropped to 148,000 by last week (above)
People 12 years of age and older get two 30 microgram (μg) doses of the vaccine.
However, a 10 μg dose was given to children aged five to 11 years and a three μg dose to children aged six months to four years.
Unlike the larger clinical trial conducted in adults, the pediatric trial did not measure efficacy by comparing the number of COVID-19 cases among the vaccine group to the number of placebo group.
Instead, the scientists looked at the levels of neutralizing antibodies in young vaccine recipients and compared the levels to those seen in adults.
The companies expect data on how well the vaccine works in children aged two to five years and those between six months and two years of age by the end of the year.
Most recently, pediatric cases rose from 71,000 per week in early August to more than 243,000 in early September, driven by the delta version.
However, they are now trending downward, with about 148,000 reported last week, according to the American Academy of Pediatrics.
There have also been 520 child deaths since the start of the pandemic, indicating that children account for less than 0.1 percent of all deaths.
Currently, no evidence suggests that the delta variant is more dangerous in children than previous strains of the virus.
Because of this low risk of serious illness, surveys have shown that many parents are unwilling to vaccinate their children.
1 July 2021 SurveyMott Children’s Hospital National Poll on Children’s Health at Michigan Medicine last month, found that 39 percent of parents said their children have already received a coronavirus shot.
However, 40 percent of parents also said that it is ‘unlikely’ that their children will be vaccinated.
one more vote Axios/Ipsos in September found that 44 percent of parents of children aged five to 11 said their children were likely to get vaccinated and 42 percent said it was unlikely their children would be vaccinated. .